1011.HK

China NT Pharma Group Company Limited 1011.HK

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode 1011.HK 1652.HK 3737.HK 1942.HK 0897.HK 1643.HK 2297.HK 1612.HK 0455.HK 2389.HK
6M 124.00 % 162.96 % -26.67 % 11.11 % 20.55 % 81.33 % 60.33 % 128.95 % -25.00 % -2.63 %
YTD 211.11 % -11.25 % -33.33 % -60.40 % 81.07 % 97.10 % 84.38 % 117.50 % -21.51 % -3.90 %
1Y 115.38 % -28.28 % -29.03 % -72.22 % 116.75 % 81.33 % 96.67 % 100.00 % -28.57 % -8.64 %
3Y 976.92 % -25.26 % -8.33 % -87.22 % 37.50 % 61.90 % -88.34 % 114.81 % -28.19 % 2.78 %
5Y -28.21 % -82.47 % -56.86 % -49.37 % 49.15 % -46.03 % -94.41 % -53.48 % -15.63 % -37.82 %
10Y -99.58 % -72.05 % -72.50 % -20.00 % -75.96 % -46.03 % -94.41 % -7.45 % -64.94 % -90.26 %
From the beginning -23.64 % -72.05 % -72.38 % -20.00 % -99.99 % -46.03 % -94.41 % -7.45 % -86.50 % -97.11 %

Dividend

China NT Pharma Group Company Limited

Fusen Pharmaceutical Company Limited

Zhongzhi Pharmaceutical Holdings Limited

MOG Holdings Limited

Wai Yuen Tong Medicine Holdings Limited

Modern Chinese Medicine Group Co., Ltd.

Vincent Medical Holdings Limited